$17.09
-0.09-0.52%
al cierre: Nov 17, 4:00 PM EST
$17.05
-0.04-0.23%
Pre-comercialización: 6:26 AM EST
Comments
Loading...
Syndax Pharmaceuticals Actividad de operaciones con información privilegiada
SNDXNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Syndax Pharmaceuticals. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Syndax Pharmaceuticals.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Syndax Pharmaceuticals Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Estadísticas de propiedad de Syndax Pharmaceuticals Inc
Acciones en circulación
86.915M
Acciones en manos de personas con información privilegiada
1.276M
Porcentaje de acciones en manos de personas con información privilegiada
1.48%
Acciones en manos de instituciones
33.596M
Porcentaje de acciones en manos de instituciones
38.7%
Sep 08, 2025 | CHIEF EXECUTIVE OFFICER | 0.00 | $13.66 | -$867.38K | SELL-OPTIONS | 0.00% | 298.66K | Sep 08 | ||
Aug 18, 2025 | — | 0.00 | $11.20 | -$460.38K | SELL-OPTIONS | 0.00% | 191.76K | Aug 14 - Aug 18 | ||
Jul 18, 2025 | CHIEF FINANCIAL OFFICER | -1.30K | $9.29 | -$12.03K | SELL | -1.38% | 92.45K | Jul 16 | ||
Jul 18, 2025 | CHIEF EXECUTIVE OFFICER | -7.53K | $9.29 | -$69.95K | SELL | -2.46% | 298.66K | Jul 16 | ||
May 19, 2025 | CHIEF FINANCIAL OFFICER | 3.00K | $0.00 | $0.00 | BUY | 3.31% | 93.75K | May 19 | ||
May 19, 2025 | HEAD R&D, CMO | 11.77K | $8.99 | $105.83K | BUY | 50.28% | 35.16K | May 16 | ||
May 19, 2025 | — | 5.00K | $8.99 | $44.95K | BUY | 6.76% | 79.00K | May 19 | ||
May 19, 2025 | — | 10.00K | $9.11 | $91.12K | BUY | 11.11% | 100.00K | May 19 | ||
Mar 06, 2025 | CHIEF EXECUTIVE OFFICER | 0.00 | $11.12 | -$61.30K | SELL-OPTIONS | 0.00% | 300.12K | Mar 04 | ||
Feb 12, 2025 | CHIEF FINANCIAL OFFICER | -3.78K | $15.50 | -$58.56K | SELL | -4.00% | 90.75K | Feb 10 | ||
Feb 12, 2025 | CHIEF EXECUTIVE OFFICER | -13.29K | $15.50 | -$206.02K | SELL | -4.24% | 300.12K | Feb 10 | ||
Feb 12, 2025 | PRESIDENT, HEAD R&D | -4.62K | $15.50 | -$71.60K | SELL | -5.15% | 85.09K | Feb 10 | ||
Jun 17, 2024 | CHIEF FINANCIAL OFFICER | 1.25K | $20.03 | $25.04K | BUY | 2.43% | 52.62K | Jun 14 | ||
Aug 10, 2023 | — | 0.00 | $13.52 | -$501.86K | SELL-OPTIONS | 0.00% | 17.84K | Aug 09 | ||
Aug 03, 2023 | — | 0.00 | $14.24 | -$1.03M | SELL-OPTIONS | 0.00% | 48.00K | Aug 02 | ||
Jul 11, 2023 | — | 0.00 | $14.58 | -$614.53K | SELL-OPTIONS | 0.00% | 17.84K | Jul 10 | ||
Jun 14, 2023 | CHIEF FINANCIAL OFFICER | -577.00 | $22.31 | -$12.87K | SELL | -18.00% | 2.63K | Jun 13 | ||
Jun 09, 2023 | — | 0.00 | $14.42 | -$714.63K | SELL-OPTIONS | 0.00% | 17.84K | Jun 09 | ||
May 10, 2023 | — | 0.00 | $13.89 | -$794.26K | SELL-OPTIONS | 0.00% | 17.84K | May 09 | ||
Apr 12, 2023 | — | 0.00 | $12.95 | -$695.02K | SELL-OPTIONS | 0.00% | 17.84K | Apr 10 | ||
Mar 14, 2023 | PRESIDENT, HEAD R&D | 0.00 | $14.45 | -$853.47K | SELL-OPTIONS | 0.00% | 17.84K | Mar 13 | ||
Feb 17, 2023 | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.40 | -$472.30K | SELL-OPTIONS | 0.00% | 0.00 | Feb 15 | ||
Feb 08, 2023 | CHIEF EXECUTIVE OFFICER | 0.00 | $17.01 | -$126.68K | SELL-OPTIONS | 0.00% | 17.66K | Feb 06 | ||
Feb 08, 2023 | PRESIDENT, HEAD R&D | 0.00 | $16.60 | -$1.08M | SELL-OPTIONS | 0.00% | 17.84K | Feb 06 | ||
Feb 03, 2023 | CHIEF SCIENTIFIC OFFICER | 0.00 | $22.87 | -$766.46 | ACQ/DIS | 0.00% | 0.00 | Jan 31 - Feb 01 | ||
Jan 13, 2023 | — | 0.00 | $18.95 | -$615.80K | SELL-OPTIONS | 0.00% | 32.00K | Jan 12 - Jan 13 | ||
Dec 02, 2022 | CHIEF SCIENTIFIC OFFICER | 0.00 | $15.71 | -$466.64K | SELL-OPTIONS | 0.00% | 265.00 | Dec 01 - Dec 02 | ||
Oct 07, 2022 | — | 0.00 | $17.05 | -$529.23K | SELL-OPTIONS | 0.00% | 32.00K | Oct 06 | ||
Oct 07, 2022 | CHIEF EXECUTIVE OFFICER | 0.00 | $17.03 | -$268.16K | SELL-OPTIONS | 0.00% | 17.66K | Oct 06 | ||
Oct 04, 2022 | CHIEF EXECUTIVE OFFICER | 0.00 | $16.89 | -$548.74K | SELL-OPTIONS | 0.00% | 17.66K | Sep 30 - Oct 04 | ||
Oct 04, 2022 | — | 0.00 | $16.58 | -$69.53K | SELL-OPTIONS | 0.00% | 32.00K | Sep 30 - Oct 04 | ||
Sep 21, 2022 | PRESIDENT, HEAD R&D | 0.00 | $17.00 | -$2.12M | SELL-OPTIONS | 0.00% | 17.84K | Sep 19 - Sep 20 | ||
Sep 16, 2022 | PRESIDENT, HEAD R&D | 0.00 | $15.77 | -$4.40M | SELL-OPTIONS | 0.00% | 17.84K | Sep 14 - Sep 16 | ||
Sep 16, 2022 | — | 0.00 | $15.20 | -$1.40M | SELL-OPTIONS | 0.00% | 75.76K | Sep 15 - Sep 16 | ||
Aug 26, 2022 | CHIEF SCIENTIFIC OFFICER | 265.00 | $15.72 | -$464.09K | SELL-OPTIONS | ∞ | 265.00 | Jul 29 - Aug 24 | ||
Aug 09, 2022 | — | 0.00 | $16.12 | -$331.06K | SELL-OPTIONS | 0.00% | 32.00K | Aug 05 | ||
Jul 27, 2022 | CHIEF EXECUTIVE OFFICER | 0.00 | $13.72 | -$463.77K | SELL-OPTIONS | 0.00% | 17.66K | Jul 25 | ||
Jul 08, 2022 | CHIEF EXECUTIVE OFFICER | 0.00 | $13.73 | -$222.01K | SELL-OPTIONS | 0.00% | 17.66K | Jul 06 - Jul 07 | ||
Jul 05, 2022 | PRESIDENT, HEAD R&D | 0.00 | $13.10 | -$734.93K | SELL-OPTIONS | 0.00% | 17.84K | Jul 01 | ||
Apr 05, 2022 | PRESIDENT, HEAD R&D | -30.50K | $14.19 | -$1.02M | SELL | -63.10% | 17.84K | Apr 01 - Apr 04 | ||
Feb 03, 2022 | CHIEF SCIENTIFIC OFFICER | 0.00 | $14.52 | -$6.02K | ACQ/DIS | 0.00% | 0.00 | Jan 31 - Feb 01 | ||
Feb 03, 2022 | CHIEF ACCOUNTING OFFICER | 0.00 | $14.52 | -$4.12K | ACQ/DIS | 0.00% | 0.00 | Jan 31 - Feb 01 | ||
Dec 22, 2021 | — | 0.00 | $14.54 | -$617.74K | SELL-OPTIONS | 0.00% | 16.00K | Dec 20 - Dec 22 | ||
Dec 20, 2021 | CHIEF EXECUTIVE OFFICER | 0.00 | $15.45 | -$319.92K | SELL-OPTIONS | 0.00% | 48.34K | Dec 17 | ||
Dec 20, 2021 | PRESIDENT AND COO | 0.00 | $13.79 | -$1.05M | SELL-OPTIONS | 0.00% | 17.66K | Dec 16 - Dec 20 | ||
Dec 15, 2021 | PRESIDENT AND COO | 0.00 | $12.74 | -$462.28K | SELL-OPTIONS | 0.00% | 17.66K | Dec 13 | ||
Nov 19, 2021 | — | 0.00 | $13.48 | -$127.74K | SELL-OPTIONS | 0.00% | 16.00K | Nov 18 | ||
Oct 27, 2021 | PRESIDENT AND COO | 0.00 | $13.18 | -$728.96K | SELL-OPTIONS | 0.00% | 17.66K | Oct 25 - Oct 26 | ||
Sep 28, 2021 | PRESIDENT AND COO | 0.00 | $13.36 | -$300.89K | SELL-OPTIONS | 0.00% | 17.66K | Sep 27 | ||
Sep 22, 2021 | PRESIDENT AND COO | 0.00 | $13.21 | -$439.61K | SELL-OPTIONS | 0.00% | 17.66K | Sep 20 - Sep 22 | ||
Sep 21, 2021 | CHIEF EXECUTIVE OFFICER | 0.00 | $13.63 | -$904.77K | SELL-OPTIONS | 0.00% | 48.34K | Sep 17 - Sep 20 | ||
Sep 15, 2021 | PRESIDENT AND COO | 0.00 | $13.16 | -$726.83K | SELL-OPTIONS | 0.00% | 17.66K | Sep 13 - Sep 14 | ||
Aug 20, 2021 | — | 0.00 | $11.82 | -$123.12K | SELL-OPTIONS | 0.00% | 16.00K | Aug 18 | ||
May 20, 2021 | — | 0.00 | $12.97 | -$154.65K | SELL-OPTIONS | 0.00% | 16.00K | May 18 | ||
Apr 28, 2021 | SVP, CHIEF MEDICAL OFFICER | 500.00 | $15.46 | $7.73K | BUY | 3.30% | 15.67K | Apr 26 | ||
Apr 22, 2021 | — | 13.97K | $14.11 | $197.08K | BUY | 47.62% | 43.30K | Apr 22 | ||
Mar 03, 2021 | — | 0.00 | $15.33 | -$183.89K | SELL-OPTIONS | 0.00% | 16.00K | Mar 01 | ||
Feb 10, 2021 | CHIEF EXECUTIVE OFFICER | 0.00 | $13.87 | -$469.28K | SELL-OPTIONS | 0.00% | 48.34K | Feb 08 | ||
Feb 03, 2021 | PRESIDENT AND COO | 0.00 | $13.69 | -$194.80K | SELL-OPTIONS | 0.00% | 17.66K | Feb 01 | ||
Dec 03, 2020 | — | 0.00 | $15.08 | -$236.51K | OPTION EXERCISE | 0.00% | 17.66K | Dec 01 | ||
Nov 25, 2020 | — | 0.00 | $13.12 | -$601.81K | OPTION EXERCISE | 0.00% | 0.00 | Nov 23 | ||
Nov 12, 2020 | — | 0.00 | $13.62 | -$1.03M | OPTION EXERCISE | 0.00% | 46.56K | Nov 09 - Nov 10 | ||
Nov 06, 2020 | — | 0.00 | $13.76 | -$1.31M | OPTION EXERCISE | 0.00% | 17.66K | Nov 04 | ||
Feb 05, 2020 | — | 12.50K | $8.00 | $100.00K | PURCHASE | 39.81% | 43.90K | Feb 04 | ||
Oct 11, 2019 | CHIEF EXECUTIVE OFFICER | 11.00K | $5.40 | $59.40K | BUY | 53.92% | 31.40K | Oct 10 | ||
May 13, 2019 | CHIEF EXECUTIVE OFFICER | 20.40K | $7.46 | $152.24K | BUY | ∞ | 20.40K | May 09 - May 13 | ||
Mar 22, 2019 | SVP, CHIEF MEDICAL OFFICER | 1.10K | $4.92 | $5.44K | BUY | 18.05% | 7.22K | Mar 21 | ||
Nov 07, 2018 | SVP, CHIEF MEDICAL OFFICER | 200.00 | $4.79 | $958.00 | BUY | 9.10% | 2.40K | Oct 30 | ||
Apr 03, 2018 | CHIEF SCIENTIFIC OFFICER | 0.00 | $9.04 | -$89.40K | SELL-OPTIONS | 0.00% | 0.00 | Apr 03 | ||
May 19, 2017 | CHIEF SCIENTIFIC OFFICER | -4.27K | $9.04 | -$72.75K | SELL | -100.00% | 0.00 | May 17 | ||
Mar 08, 2016 | DIRECTOR | 750.54K | $12.00 | $1.80M | BUY | ∞ | 750.54K | Mar 08 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.